BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL, Tierney AR, Heitjan DF, Meier P, Ascheim DD, Levitan RG, Weinberg AD, Stevenson LW, Shapiro PA, Lazar RM, Watson JT, Goldstein DJ, Gelijns AC. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg 1999;67:723-30. [PMID: 10215217 DOI: 10.1016/s0003-4975(99)00042-9] [Cited by in Crossref: 274] [Cited by in F6Publishing: 28] [Article Influence: 11.9] [Reference Citation Analysis]
Number Citing Articles
1 Kociol RD. Don't Be a One-Trick Pony. J Card Fail 2016;22:399-401. [PMID: 26876791 DOI: 10.1016/j.cardfail.2016.02.001] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Couper GS. Ventricular assist devices and artificial hearts: Mechanical solutions to the biological problem of congestive heart failure. Transplantation Reviews 2001;15:210-31. [DOI: 10.1016/s0955-470x(01)80020-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
3 Stevenson LW. Left Ventricular Assist Devices as Destination Therapy for End-stage Heart Failure. Curr Treat Options Cardiovasc Med 2004;6:471-9. [PMID: 15496264 DOI: 10.1007/s11936-004-0004-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
4 Antaki JF. Insanity of left ventricular assist therapy: doing the same thing and expecting different results. Circ Heart Fail 2011;4:680-1. [PMID: 22086829 DOI: 10.1161/CIRCHEARTFAILURE.111.964650] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Hrobowski T, Lanfear DE. Ventricular assist devices: is destination therapy a viable alternative in the non-transplant candidate? Curr Heart Fail Rep 2013;10:101-7. [PMID: 23129352 DOI: 10.1007/s11897-012-0123-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
6 Holman WL. Mechanical circulatory support: expanding knowledge and experience in a challenging patient subset. Intensive Care Med 2001;27:1245-6. [PMID: 11511934 DOI: 10.1007/s001340101030] [Reference Citation Analysis]
7 Fouad YM, Yehia R. Hepato-cardiac disorders. World J Hepatol 2014; 6(1): 41-54 [PMID: 24653793 DOI: 10.4254/wjh.v6.i1.41] [Cited by in Crossref: 75] [Cited by in F6Publishing: 51] [Article Influence: 9.4] [Reference Citation Analysis]
8 Kapuria D, Khumri T, Shamim S, Surana P, Khan S, Al-Khalisi N, Aggarwal S, Koh C, Chhabra R. Characterization and timing of gastrointestinal bleeding in continuous flow left ventricular assist device recipients. Heliyon 2020;6:e04695. [PMID: 32939410 DOI: 10.1016/j.heliyon.2020.e04695] [Reference Citation Analysis]
9 Ahsan I, Faraz A, Mehmood A, Ullah W, Ghani AR. Clinical Approach to Manage Gastrointestinal Bleeding with a Left Ventricular Assist Device (LVAD). Cureus 2019;11:e6341. [PMID: 31938629 DOI: 10.7759/cureus.6341] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Thrush PT, Canter CE. Looking to the future of ventricular assist devices in pediatric cardiomyopathy. Progress in Pediatric Cardiology 2015;39:21-3. [DOI: 10.1016/j.ppedcard.2015.01.003] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Elliott P. Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy. Heart. 2000;84:106-112. [PMID: 10862601 DOI: 10.1136/heart.84.1.106] [Cited by in Crossref: 106] [Cited by in F6Publishing: 73] [Article Influence: 4.8] [Reference Citation Analysis]
12 Poole-Wilson PA. Patients who have dilated cardiomyopathy must have a trial of bridge to recovery: the case against that proposition. Heart Fail Clin 2007;3:317-9. [PMID: 17723939 DOI: 10.1016/j.hfc.2007.05.007] [Reference Citation Analysis]
13 Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 2010;29:1-10. [PMID: 20123242 DOI: 10.1016/j.healun.2009.10.009] [Cited by in Crossref: 294] [Cited by in F6Publishing: 217] [Article Influence: 24.5] [Reference Citation Analysis]
14 Wilmot I, Lorts A, Morales D. Pediatric mechanical circulatory support. Korean J Thorac Cardiovasc Surg 2013;46:391-401. [PMID: 24368965 DOI: 10.5090/kjtcs.2013.46.6.391] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
15 Pinto‐salinas M, Morón‐castro J, Chavarri‐velarde F, Soplopuco‐palacios F, Palma‐ortecho L, Lescano‐alva M. Heart transplantation at the Peruvian National Heart Institute: One‐decade single‐center experience. Journal of Cardiac Surgery. [DOI: 10.1111/jocs.16429] [Reference Citation Analysis]
16 Mouquet F, Susen S, Van Belle E, Bauters C, Jude B. [Cell therapy to treat heart failure]. Rev Med Interne 2003;24:401-4. [PMID: 12814831 DOI: 10.1016/s0248-8663(03)00133-4] [Reference Citation Analysis]
17 Tseng CC, Ramjankhan FZ, de Jonge N, Chamuleau SA. Advanced Strategies for End-Stage Heart Failure: Combining Regenerative Approaches with LVAD, a New Horizon? Front Surg 2015;2:10. [PMID: 25905105 DOI: 10.3389/fsurg.2015.00010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
18 Barić D. Why pulsatility still matters: a review of current knowledge. Croat Med J 2014;55:609-20. [PMID: 25559832 DOI: 10.3325/cmj.2014.55.609] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
19 Portner PM. The state of destination therapy for the treatment of congestive heart failure. Current Opinion in Organ Transplantation 2006;11:546-52. [DOI: 10.1097/01.mot.0000244642.62599.d7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Fitzpatrick JR 3rd, Frederick JR, Hiesinger W, Hsu VM, McCormick RC, Kozin ED, Laporte CM, O'Hara ML, Howell E, Dougherty D, Cohen JE, Southerland KW, Howard JL, Paulson EC, Acker MA, Morris RJ, Woo YJ. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg 2009;137:971-7. [PMID: 19327526 DOI: 10.1016/j.jtcvs.2008.09.021] [Cited by in Crossref: 214] [Cited by in F6Publishing: 175] [Article Influence: 16.5] [Reference Citation Analysis]
21 Fitzpatrick JR 3rd, Frederick JR, Hsu VM, Kozin ED, O'Hara ML, Howell E, Dougherty D, McCormick RC, Laporte CA, Cohen JE, Southerland KW, Howard JL, Jessup ML, Morris RJ, Acker MA, Woo YJ. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant 2008;27:1286-92. [PMID: 19059108 DOI: 10.1016/j.healun.2008.09.006] [Cited by in Crossref: 284] [Cited by in F6Publishing: 229] [Article Influence: 21.8] [Reference Citation Analysis]
22 Topol EJ. Economics and quality of care for patients with acute coronary syndromes: the impending crisis. Clin Cardiol 2002;25:I9-15. [PMID: 12428814 DOI: 10.1002/clc.4960251304] [Reference Citation Analysis]
23 Campos Rubio V. Criterios hemodinámicos y funcionales de indicación de una asistencia en la insuficiencia cardíaca aguda (shock cardiogénico). Cirugía Cardiovascular 2009;16:99-104. [DOI: 10.1016/s1134-0096(09)70153-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Hubbert L, Peterzén B, Ahn H, Janerot-Sjoberg B. Second harmonic echocardiography and spontaneous contrast during implantation of a left ventricular assist device. ASAIO J 2010;56:417-21. [PMID: 20613488 DOI: 10.1097/MAT.0b013e3181e9261d] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Longobardo L, Kramer C, Carerj S, Zito C, Jain R, Suma V, Thohan V, Sulemanjee N, Downey FX, Khandheria BK. Role of Echocardiography in the Evaluation of Left Ventricular Assist Devices: the Importance of Emerging Technologies. Curr Cardiol Rep 2016;18:62. [PMID: 27216842 DOI: 10.1007/s11886-016-0739-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
26 Hawkins B, Fynn-Thompson F, Daly KP, Corf M, Blume E, Connor J, Porter C, Almond C, VanderPluym C. The Evolution of a Pediatric Ventricular Assist Device Program: The Boston Children's Hospital Experience. Pediatr Cardiol 2017;38:1032-41. [PMID: 28456829 DOI: 10.1007/s00246-017-1615-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
27 Pleșoianu FA, Pleșoianu CE, Bararu Bojan I, Bojan A, Țăruș A, Tinică G. Concept, Design, and Early Prototyping of a Low-Cost, Minimally Invasive, Fully Implantable Left Ventricular Assist Device. Bioengineering 2022;9:201. [DOI: 10.3390/bioengineering9050201] [Reference Citation Analysis]
28 Bruce CR, Brody B, Majumder MA. Ethical dilemmas surrounding the use of ventricular assist devices in supporting patients with end-stage organ dysfunction. Methodist Debakey Cardiovasc J 2013;9:11-4. [PMID: 23518898 DOI: 10.14797/mdcj-9-1-11] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
29 Capoccia M. Mechanical Circulatory Support for Advanced Heart Failure: Are We about to Witness a New "Gold Standard"? J Cardiovasc Dev Dis 2016;3:E35. [PMID: 29367578 DOI: 10.3390/jcdd3040035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
30 Ying GS, Heitjan DF. Prediction of event times in the REMATCH Trial. Clin Trials 2013;10:197-206. [PMID: 23321264 DOI: 10.1177/1740774512470314] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
31 Loghmanpour NA, Druzdzel MJ, Antaki JF. Cardiac Health Risk Stratification System (CHRiSS): a Bayesian-based decision support system for left ventricular assist device (LVAD) therapy. PLoS One 2014;9:e111264. [PMID: 25397576 DOI: 10.1371/journal.pone.0111264] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
32 Bluestein D, Chandran KB, Manning KB. Towards non-thrombogenic performance of blood recirculating devices. Ann Biomed Eng 2010;38:1236-56. [PMID: 20131098 DOI: 10.1007/s10439-010-9905-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
33 Noon GP, Loebe M, Motomura T. Respect the history and foresee the future: milestones of the International Society for Rotary Blood Pumps with Artificial Organs. Artif Organs 2012;36:656-8. [PMID: 22882436 DOI: 10.1111/j.1525-1594.2012.01517.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Mihaljevic T, Jarrett CM, Gonzalez-Stawinski G, Smedira NG, Nowicki ER, Thuita L, Mountis M, Blackstone EH. Mechanical circulatory support after heart transplantation. Eur J Cardiothorac Surg 2012;41:200-6; discussion 206. [PMID: 21640601 DOI: 10.1016/j.ejcts.2011.04.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
35 Hilal T, Mudd J, DeLoughery TG. Hemostatic complications associated with ventricular assist devices. Res Pract Thromb Haemost 2019;3:589-98. [PMID: 31624778 DOI: 10.1002/rth2.12226] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
36 Wu RC, Thorpe K, Ross H, Micevski V, Marquez C, Straus SE. Comparing administration of questionnaires via the internet to pen-and-paper in patients with heart failure: randomized controlled trial. J Med Internet Res 2009;11:e3. [PMID: 19275979 DOI: 10.2196/jmir.1106] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
37 Lewis ME, Pitt MP, Bonser RS. Surgical alternatives to mechanical support. Perfusion 2000;15:379-86. [PMID: 10926424 DOI: 10.1177/026765910001500416] [Reference Citation Analysis]
38 Marcel R, Meyer DM. An overview of approved and investigational left ventricular assist devices. Proc (Bayl Univ Med Cent) 2004;17:407-10. [PMID: 16200128 DOI: 10.1080/08998280.2004.11928003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
39 Tscheliessnigg K. Surgical Treatment of Heart Failure - A Changing Paradigm? European Surg 2002;34:347-53. [DOI: 10.1046/j.1563-2563.2002.02083.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Felker GM, O'Connor CM. Rational use of inotropic therapy in heart failure. Curr Cardiol Rep 2001;3:108-13. [PMID: 11177666 DOI: 10.1007/s11886-001-0035-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
41 Oz MC, Gelijns AC, Miller L, Wang C, Nickens P, Arons R, Aaronson K, Richenbacher W, van Meter C, Nelson K, Weinberg A, Watson J, Rose EA, Moskowitz AJ. Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg 2003;238:577-83; discussion 583-5. [PMID: 14530729 DOI: 10.1097/01.sla.0000090447.73384.ad] [Cited by in Crossref: 33] [Cited by in F6Publishing: 43] [Article Influence: 1.7] [Reference Citation Analysis]
42 Song HK, Gelow JM, Mudd J, Chien C, Tibayan FA, Hollifield K, Naftel D, Kirklin J. Limited Utility of Tricuspid Valve Repair at the Time of Left Ventricular Assist Device Implantation. Ann Thorac Surg 2016;101:2168-74. [PMID: 27139368 DOI: 10.1016/j.athoracsur.2016.03.040] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
43 Trupp RJ, Abraham WT, Lamba S. Future therapies for heart failure. Crit Care Nurs Clin North Am 2003;15:525-30, x. [PMID: 14717399 DOI: 10.1016/s0899-5885(02)00106-5] [Reference Citation Analysis]
44 Hall JL, Fermin DR, Birks EJ, Barton PJ, Slaughter M, Eckman P, Baba HA, Wohlschlaeger J, Miller LW. Clinical, molecular, and genomic changes in response to a left ventricular assist device. J Am Coll Cardiol 2011;57:641-52. [PMID: 21292124 DOI: 10.1016/j.jacc.2010.11.010] [Cited by in Crossref: 95] [Cited by in F6Publishing: 75] [Article Influence: 8.6] [Reference Citation Analysis]
45 Thyagarajan B, Kumar MP, Sikachi RR, Agrawal A. Endocarditis in left ventricular assist device. Intractable Rare Dis Res 2016;5:177-84. [PMID: 27672540 DOI: 10.5582/irdr.2016.01049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
46 Martens P, Vercammen J, Ceyssens W, Jacobs L, Luwel E, Van Aerde H, Potargent P, Renaers M, Dupont M, Mullens W. Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure. ESC Heart Fail 2018;5:562-9. [PMID: 29341466 DOI: 10.1002/ehf2.12248] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
47 Hubbert L, Sundbom P, Loebe M, Peterzén B, Granfeldt H, Ahn H. Acoustic analysis of a mechanical circulatory support. Artif Organs 2014;38:593-8. [PMID: 24372095 DOI: 10.1111/aor.12244] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
48 Donahey EE, Polly DM, Vega JD, Lyon M, Butler J, Nguyen D, Pekarek A, Wittersheim K, Kilgo P, Paciullo CA. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices. Tex Heart Inst J 2015;42:522-7. [PMID: 26664303 DOI: 10.14503/THIJ-14-4612] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]